Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Comment by jopatcloon Oct 03, 2024 12:55pm
39 Views
Post# 36251936

RE:The Take Heart Conference is organized by the OHHF🚀

RE:The Take Heart Conference is organized by the OHHF🚀
jopatclo wrote:
Dear Friend;
 
Attached is today’s news release.  Here is some background:
 
1. The Take Heart Conference is organized by the Ollie Hinkle Heart Foundation, which works with a number of top cardiac hospitals to introduce new technology into their paediatric units.
2. Dr. Brian Soriano, a cardiologist at Seattle Children's Hospital and Associate Professor in the Department of Pediatrics at the University of Washington School of Medicine will present his experience with the VMS+ at the opening session of the Conference on October 4.
3. Dr. Soriano is a long-time user of the VMS+ and has recently upgraded his device to VMS+3.2.  He has published research studies showing its use and equivalency to MRI in patients with a wide range of heart conditions.
4. We are working with the Ollie Hinkle Heart Foundation to introduce the VMS+ to their partner hospitals and the Foundation is securing donations to facilitate the adoption of our innovative whole-heart analysis system.
 
Thank you for the support and interest as we continue to improve cardiac diagnostics for everyone, everywhere, and especially for children born wth a heart defect.
 
Regards,
 
Dr. George Adams ICD.D
Executive-Chairman
Ventripoint Diagnostics Ltd.
TSXV-VPT

Now 0.185 $ Maybe news before the Take Heart conference Tic..tac..FDA V4.0 and Sales at any time now Insiders know!
12:53 R 0,185  0,015 0,185 0,19 21 500 / 25 000 202,20k 0,185 0,17

<< Previous
Bullboard Posts
Next >>